Efficacy of Fu's Subcutaneous Needling for Trigeminal Neuralgia :A prospective, self-controlled trial
- Conditions
- Trigeminal Neuralgia
- Registration Number
- ITMCTR2200005655
- Lead Sponsor
- Yangzhou Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
A. At least three attacks of unilateral facial pain fulfilling criteria B and C
B. Occurring in one or more divisions of the trigeminal nerve, with no radiation beyond the trigeminal distribution
C. Pain has at least three of the following four characteristics:
a. recurring in paroxysmal attacks lasting from a fraction of a second to 2 minutes
b. severe intensity
c. electric shock-like, shooting, stabbing or sharp in quality
d. precipitated by innocuous stimuli to the affected side of the face
D. No clinically evident neurological deficit
E. Not better accounted for by another ICHD-3 diagnosisuced ;
F. Duration ranges from 2 weeks to 6 months at time of recruitment;
G. Age ranges from 18 to 80;
H. Signed informed consent.
Patients with STN, such as tumors in the cerebellopontine horn region, trigeminal neurilemmoma, multiple sclerosis, and other neuralgia patients confused with TN, such as odontogenic pain, herpes zoster, migraine or plexiform neuralgia; combination of heart, liver, or kidney failure endanger the safety of life at any time; younger than 18 years or older than 80 years; those who do not receive acupuncture therapy; women with pregnancy and lactation; participate in other studies; aphasia, and severe cognitive deficits.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umerical Rating Scale;medicine dosage;
- Secondary Outcome Measures
Name Time Method Barrow Neurology Institute Pain Scale scores;Patient Global Impression of Change scores;Brief Pain Inventory–Facial scores;the Constant Face Pain Questionnaire scores;